Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiping Yang

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Cancers|February 10, 2019
Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future StrategiesBenjamin Heyman, Yiping Yang
Experimental Hematology|August 31, 2016
Mechanisms of heparanase inhibitors in cancer therapyBenjamin Heyman, Yiping Yang
Immunotherapy|February 25, 2017
Tumor-associated macrophages: implications in cancer immunotherapyAmy J Petty, Yiping Yang
The Journal of Clinical Investigation|April 18, 2017
PD-L1 serves as a double agent in separating GVL from GVHDTodd V Brennan, Yiping Yang
Immunologic Research|December 1, 2010
The role of natural regulatory T cells in infectionAna M Sanchez, Yiping Yang
Journal of Innate Immunity|March 18, 2011
Natural killer cell responses to viral infectionJoshua D Brandstadter, Yiping Yang
Cells|December 1, 2019
Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted TherapiesAmy J Petty, Yiping Yang
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Type I IFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirusJiangao Zhu, Xiaopei Huang, Yiping Yang
Contemporary Clinical Trials|August 21, 2022
Estimation of hurst exponent for sequential monitoring of clinical trials with covariate adaptive randomizationYiping Yang, Hongjian Zhu, Dejian Lai
JCI Insight|April 14, 2017
IL-21 is required for CD4 memory formation in response to viral infectionYuqing Yuan, Yiping Yang, Xiaopei Huang
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Cancers|February 10, 2019
Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future StrategiesBenjamin Heyman, Yiping Yang
Experimental Hematology|August 31, 2016
Mechanisms of heparanase inhibitors in cancer therapyBenjamin Heyman, Yiping Yang
Immunotherapy|February 25, 2017
Tumor-associated macrophages: implications in cancer immunotherapyAmy J Petty, Yiping Yang
The Journal of Clinical Investigation|April 18, 2017
PD-L1 serves as a double agent in separating GVL from GVHDTodd V Brennan, Yiping Yang
Immunologic Research|December 1, 2010
The role of natural regulatory T cells in infectionAna M Sanchez, Yiping Yang
Journal of Innate Immunity|March 18, 2011
Natural killer cell responses to viral infectionJoshua D Brandstadter, Yiping Yang
Cells|December 1, 2019
Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted TherapiesAmy J Petty, Yiping Yang
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Type I IFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirusJiangao Zhu, Xiaopei Huang, Yiping Yang
Contemporary Clinical Trials|August 21, 2022
Estimation of hurst exponent for sequential monitoring of clinical trials with covariate adaptive randomizationYiping Yang, Hongjian Zhu, Dejian Lai
JCI Insight|April 14, 2017
IL-21 is required for CD4 memory formation in response to viral infectionYuqing Yuan, Yiping Yang, Xiaopei Huang
Pageof 19